DOCSLIB.ORG

General Thoracic Surgery Database Training Manual Version 2.41

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
General Thoracic Surgery Database Training Manual Version 2.41 JANUARY 5, 2021 Data Manager Quick Links New Data Warehouse - Starting January 1, 2020 – Important Information for ALL SITES! Database Transition Resources STS National Database Webinars Data Manager Education Data Collection Resources (version specific abstraction documents) Ask an Abstraction Question STS National Database News - Publication for STS Data Managers Public Reporting Contact Information GENERAL THORACIC SURGERY DATABASE TRAINING MANUAL VERSION 2.41 General Thoracic Surgery Database V2.41 Training Manual January 5, 2021 Table of Contents Case Examples ............................................................................................................................................................3 Definitions ..................................................................................................................................................................4 Risk Model ..................................................................................................................................................................4 Demographics .............................................................................................................................................................5 Admission ................................................................................................................................................................ 13 Pre-Operative Evaluation ........................................................................................................................................ 18 Diagnosis (Category of Disease) .............................................................................................................................. 58 Operative ................................................................................................................................................................. 81 Lung Cancer ............................................................................................................................................................ 124 Esophageal Cancer .................................................................................................................................................. 156 Thymus/Mediastinal Mass Resection ....................................................................................................................... 169 Tracheal Resection .................................................................................................................................................. 181 Hiatal Hernia / GERD ............................................................................................................................................... 193 Disposition .............................................................................................................................................................. 217 Post – Operative Events .......................................................................................................................................... 219 Discharge ................................................................................................................................................................ 261 Follow Up................................................................................................................................................................ 268 Quality Measures .................................................................................................................................................... 269 Resources .............................................................................................................................................................. 274 2 | P a g e General Thoracic Surgery Database V2.41 Training Manual January 5, 2021 Case Examples The STS General Thoracic Registry version 2.41 requires submission of all lung resections for primary lung cancer and all esophageal resections for primary esophageal cancer. Lung and esophageal resections for primary cancer are analyzed including national outcomes for benchmarking, risk adjusted outcomes, and star rating. Participants in the General Thoracic Registry may choose to submit Thymus/Mediastinal Mass Resection, Tracheal Resection, and Hiatal Hernia/GERD cases. These case types are optional modules for submission to the registry and will be analyzed in the national report if submitted. All other case types are not required for collection or submission. They will not be analyzed in the aggregate report if submitted. Case #1: Patient has nodule on CT scan and is also worked up with a PET scan. Surgeon thinks it could be cancer so lung resection is completed and path comes back as lung cancer. This case is required for the registry. Enter this case as a lobectomy for primary lung cancer including the clinical and path staging. Case #2: Same as above but path comes back as hamartoma. This case is not required for submission to the registry because resection ultimately was not for primary lung cancer. This case will not be analyzed if submitted. Case #3 Patient worked up for presumed lung cancer and taken to OR for planned wedge resection followed by lobectomy if frozen section shows cancer. Frozen section comes back as granuloma so surgery ends at wedge resection. This case is not required for submission because resection ultimately was not for lung cancer. This case would not be analyzed if submitted. Case #4 Patient presents to hospital with pneumonia. CT shows necrotic fluid suspicious for lung abscess in LLL. Patient taken to OR to drain effusion and wedge resection of abscess. Completion lobectomy was then undertaken because the lung was not salvageable. There was never suspected cancer. This case is not required for submission because resection ultimately was not for lung cancer. This case would not be analyzed if submitted. Case #5 Patient with history of breast cancer and previous mets to the lung removed via wedge and presents now with a new nodule. Surgeon assumes it’s another met. Taken to OR for therapeutic wedge resection. Final pathology returns as early stage primary lung cancer. This case is required for the registry. Enter this case as a wedge resection for primary lung cancer including the clinical and pathological staging. This case will be analyzed. Case #6 Patient presents with empyema and undergoes decortication. This case is not required for submission to the registry because it is not a lung resection for primary lung cancer. This case will not be analyzed if submitted. 3 | P a g e General Thoracic Surgery Database V2.41 Training Manual January 5, 2021 Case #7 Patient presents with mediastinal mass. Ultimately undergoes thymectomy. Pathology returns with stage II thymoma. This case is an optional submission using the Thymus/Mediastinal Mass module. This case will be analyzed if submitted. Definitions “No” should be indicated if there is documentation that the patient does not have Pulmonary Hypertension. “Unknown” should be indicated if it is not known if the patient has Pulmonary Hypertension or if testing has not been performed. Risk Model The risk model is an all or none model. Within the risk model complications are not tallied or delineated. The patient either has complications or they do not. Therefore, all complications / post-operative events are to be captured. 4 | P a g e General Thoracic Surgery Database V2.41 Training Manual January 5, 2021 Demographics SeqNo: 10 Long Name: Operations Table Record Identifier Short Name: RecordID Definition: An arbitrary, unique value generated by the software that permanently identifies each record in the participant's database (note that unlike the PatID value, this does not identify the individual patient). The value of the identifier is a combination of a code assigned to the software developer by the STS, and a value generated by the software to create a unique value. Once assigned to a record, this value can never be changed or reused. The data warehouse will use this value to communicate issues about individual records with the participant. It may also be used by the data warehouse to link this record to other clinical data. Intent/Clarification: A record should be initiated for inpatient and outpatient thoracic procedures on every visit to the operating room (includes Endoscopy Suite or Outpatient Surgical Center) whether planned or unplanned. SeqNo: 20 Long Name: Procedures Table Record Identifier Short Name: RecordID Definition: This field is the foreign key that links this record with the associated records in the "Operations" table. SeqNo: 30 Long Name: Software Vendor's Identification Short Name: VendorID Definition: Software vendor's identification assigned by the STS. SeqNo: 40 Long Name: Vendor's Software Version Number Short Name: SoftVrsn Definition: Vendor's software product version number identifying the software which created this record. Vendor controls the value in this field. Version passing certification/harvest testing will be noted at the data warehouse. SeqNo: 50 Long Name: Version Of STS Data Specification Short Name: DataVrsn Definition: Version number of the STS Data Specifications/Dictionary, to which the record conforms. The value will identify which fields should have data, and what are the valid data values for those fields. It must 5 | P a g e General Thoracic Surgery Database V2.41 Training Manual January 5, 2021 be the version implemented in the software at the time the record was
Load more

Recommended publications
  • Surgical Management of Empysema
    Surgical Management of Empysema John A Odell MB ChB, FRCS(Ed), FACS Emeritus Professor of Surgery Mayo Clinic College of Medicine Previously Surgical Director Lung Transplantation ©2013 MFMER | slide-1 Problem case. How would you manage? • 64yr male • Previous RLL bullectomy. • Recent left pneumothorax managed elsewhere with chest tube placement. • Because of continued air-leak talc pleurodesis. • Air-leak continues. ©2013 MFMER | slide-2 • On nasal oxygen. Dyspneic on walking • Significant air-leak. More dyspneic when suction applied to chest drain. • FEV1 40% predicted. DLCO 12% predicted. Options? • Thoracotomy and close air leak surgically • Videothoracoscopy and closure of air-leak • Thoracotomy and decortication • Remove chest drain • List for transplantation Historical Treatment of Emphysema • Abdominal compression belts. The stimulus was the observation that emphysematous patients lean forward when breathing. • Pneumoperitoneum. In an attempt to restore diaphragmatic curvature. • Lungs too large for the chest – costochondrectomy or transverse sternotomy to provide more room. Multiple wedge excisions. • Chest grown too large – thoracoplasty • Pleurodesis. Emphysema results from alveolar wall ischemia. • Phrenectomy. Overvigerous inspiration was ripping alveolar walls. • Hilar denervation. To decrease bronchoconstriction and mucous production mediated by the parasympathetic nervous system. • Whole lung irradiation. To increase elastic recoil by inducing fibrosis. ©2013 MFMER | slide-7 Variants of Emphysema that may be Surgically
    [Show full text]
  • Effect of an Indwelling Pleural Catheter Vs Talc Pleurodesis On
    This supplement contains the following items: 1. Original protocol, final protocol, summary of changes. 2. Original statistical analysis plan. There were no further changes to the original statistical analysis plan. Downloaded From: https://jamanetwork.com/ on 10/02/2021 The Australasian Malignant Pleural Effusion Trial (AMPLE) A Multicentre Randomized Study Comparing Indwelling Pleural Catheter vs Talc Pleurodesis in Patients with Malignant Pleural Effusions Ethics Registration number 2012-005 Protocol version number 1.0 Protocol date 10/01/2012 Authorised by: Name: Prof YC Gary Lee Role: Chief Investigator Signature: Date: 10/01/2012 Downloaded From: https://jamanetwork.com/ on 10/02/2021 General Information This document describes the Western Australian Randomised Malignant Effusion trial for the purpose of submission for review by the relevant human research and ethics committees. It provides information about procedures for entering patients into the trial and this protocol should not be used as a guide for the treatment of other patients; every care was taken in its drafting, but corrections or amendments may be necessary. Questions or problems relating to this study should be referred to the Chief Investigator or Trial Coordinator. Compliance The trial will be conducted in compliance with this protocol, the National Statement on Ethical Conduct in Human Research, data protection laws and other guidelines as appropriate. It will be registered with the Australia and New Zealand Clinical Trials Registry, once ethical approval is secured.
    [Show full text]
  • 2019 Coding and Payment Information Pleural Effusions and Ascites Management
    2019 coding and payment information Pleural effusions and ascites management The information contained in this document, including Reimbursement rates shown are Medicare national the codes supplied, is provided for informational payments for 2019 and do not reflect actual payments purposes only. BD makes no statement, promise or made to individual providers, as payments are adjusted guarantee concerning the appropriateness of any codes specific to particular geographic regions. for a particular procedure, actual levels of All information is subject to change without notice. In reimbursement, payment or charge or that addition, payers or local carriers may have their own reimbursement will be made. coding and billing requirements. Consult your payer This is not intended to be a comprehensive guide to all organization with regard to local reimbursement policies. coding and payment information. 2019 Medicare outpatient facility rates CPT® 2019 APC OPPS 2019 ASC Description APC Status code base rate* base rate Pleural catheter procedures 32550 Insertion of indwelling tunneled pleural catheter 5341 J1 $2,947 $1,790 32552 Removal of indwelling tunneled pleural catheter with cuff 5181 Q2 $620 $319 32560 Instillation via chest tube/catheter, agent for pleurodesis 5181 T $620 N/A 32650 Thoracoscopy, surgical, with pleurodesis (e.g., mechanical or chemical) N/A; inpatient procedure Peritoneal catheter procedures Insertion of tunneled intraperitoneal catheter (e.g., dialysis, intraperitoneal chemotherapy instillation, management of ascites), 49418
    [Show full text]
  • FAQ Document
    The Society of Thoracic Surgeons Frequently Asked Questions: General Thoracic Database Version 2.07 December 2008 How to use the “interactive” FAQ Document: 1. To review all clinical questions in an individual section, click on the section title below. Section A: seq# 10 - 190 Section C: seq# 285 - 650 Section E: seq# 770 - 1210 Section B: seq# 200 - 260 Section D: seq# 660 - 750 Section F: seq# 1220 - 1340 2. To review an individual Seq# clinical question, click on the Seq# title below. Participation in both General Thoracic and Adult Cardiac Databases GENERAL STATEMENT #2 Seq# 200: Zubrod Score Seq# 775: Postop Events Seq# 300: WtLoss3Kg Seq# 860: Pneumonia Seq# 310: Category of disease Seq# 930: Other Pulmonary Event Seq# 390: PreOp Chemotherapy Seq# 940: Atrial Arrhythmia Seq# 400: PreOp Thoracic RT Seq# 1020: Anastomotic leak Seq# 430: Other Cormorbidity Seq# 1190: Empyema Seq# 540: Clinical Stage Not Applicable (2.06) Seq# 1200: Other event req. Rx Seq# 725: Reoperation Seq# 1250: 30 Day Status Seq# 740: Procedure Seq# 1280: Chest Tube Out Date Seq# 750: Primary Procedure Seq# 751: Thoracoscopy Approach NEW Date SeqNo FieldName Definition 3/06 Participation in both General We participate in both Adult Cardiac and Yes, enter into both. In the Adult Cardiac DB, the Thoracic and Adult Cardiac General Thoracic Database. Our question primary procedure would be Seq# 1310 pertains to whether the patient should end up OpOCard=Yes; Seq# 2510 ONCAoAn=Yes; Databases in both databases. Scenario--We had a Seq# 2530 ONCArch=Yes; Seq# 2540 patient who had an aortic aneurysm repair ONCDesc=Yes; Seq# 3220 Readm30=Yes; (arch/descending thoracic) and was entered Seq# ReadmRsn=either Pneumonia or other into the Adult Cardiac Database.
    [Show full text]
  • Effectiveness and Superiority of Ventilation with Laryngeal Mask
    a & hesi C st lin e ic n a A l f R o e l s Journal of Anesthesia & Clinical e a a n r r Wu et al., J Anesth Clin Res 2017, 8:7 c u h o J DOI: 10.4172/2155-6148.1000738 ISSN: 2155-6148 Research Research Article Open Access Effectiveness and Superiority of Ventilation with Laryngeal Mask Airway in Partial Laryngectomy Jinhong Wu, Weixing Li and Wenxian Li* Department of Anesthesiology, Eye, Ear, Nose and Throat Hospital, Fudan University, China *Corresponding author: Wenxian Li, Department of Anesthesiology, Eye, Ear, Nose and Throat Hospital, Fudan University, 83 Fenyang Road, Xuhui District, Shanghai 200031, China, Tel: +86-21-64377134; Fax: +86-21-64377151; E-mail: [email protected] Received date: Jun 06, 2017; Accepted date: Jul 01, 2017; Published date: Jul 04, 2017 Copyright: © 2017 Wu J, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Abstract Background: Laryngeal carcinoma occupies the space of glottis. It may lead to difficult airway, and is prone to bleed if intubated with endotracheal tube (ETI). Intubation can also result in the possibility of tumor cultivation in the lung. Use of laryngeal mask airway (LMA) could avoid the disadvantages of endotracheal intubation, which would benefit patients undergoing partial laryngectomy. Methods: This was a randomized controlled clinical trial. Thirty adult patients scheduled to receive partial laryngectomy were enrolled. All study subjects received an ASA rating of grade III.
    [Show full text]
  • Agenda Item 5
    List A (O) Respiratory system treatments and procedures. (1) Biopsy and/or excision (removal) of lesion of larynx, vocal cords, trachea (A) Loss or change of voice. (B) Swallowing or breathing difficulties. (C) Perforation (hole) or fistula (connection) in esophagus (tube from throat to stomach). (2) Rhinoplasty (surgery to change the shape of the nose) or nasal reconstruction with or without septoplasty A) Deformity of skin, bone or cartilage. (B) Creation of new problems, such as perforation of the nasal septum (hole in wall between the right and left halves of the nose) or breathing difficulty. (3) Submucous resection of nasal septum or nasal septoplasty (surgery to remove blockage in or straighten the nose) (A) Persistence, recurrence or worsening of the obstruction. (B) Perforation of nasal septum (hole in wall between the right and left halves of the nose) with dryness and crusting. (C) External deformity of the nose. (4) Sinus surgery/endoscopic sinus surgery (A) Spinal fluid leak (B) Visual loss or other eye injury (C) Numbness in front teeth and palate (D) Loss or reduction in sense of taste or smell (E) Recurrence of disease (F) Empty Nose Syndrome (sensation of nasal congestion, sensation of not being able to take in adequate air through nose) (G) Injury to tear duct causing drainage of tears down the cheek (H) Brain injury and/or infection (I) Injury to nasal septum (J) Nasal obstruction (5) Lung biopsy (A) Air leak with pneumothorax (leak of air from lung to inside of chest causing the lung to collapse) with need for insertion of chest drainage tube into space between lung and chest wall or repeat surgery.
    [Show full text]
  • Gemstone Spectral Imaging Technique
    Gemstone Spectral Imaging HANDBOOK OF CLINICAL EVIDENCE for Radiologists and Radiographers Vascular Performance Artefact Innovation Reduction Technology Material Decomposition Oncology gehealthcare.com Introduction Diagnostic Imaging is a fast-moving field harvesting the latest technologies from the newest in hardware capabilities to the first artificial intelligence applications in radiology. The objective is improving patient clinical outcomes and we are now expecting to go beyond by improving the patient pathway, reducing the number of exams and giving access to the right diagnosis, effortlessly. CT imaging has quickly become the cornerstone of imaging departments, not only providing more and more anatomical information by improving image quality, but also taking the lead in functional information to really assess the impact of disease. Gemstone™ Spectral Imaging (GSI) is the avenue to answer challenging clinical questions by using a single scan to provide both anatomical and functional information in one study thereby reducing the number of exams needed to deliver a diagnosis. This technique is widely accepted by clinical societies and peer reviewed publications show patient & clinical outcomes. Through this handbook, you will find the latest uses of our GSI technology, its outcomes and real testimonials from our users. We truly want to help you integrate this into your daily clinical practice in multiple clinical applications to further add value to your patient care pathway in CT. We have gathered infographics illustrating the use of GSI, clinical examples from all over Europe and a brief literature review. This handbook is for your patients, for your team and for you. We hope you find it valuable and as always contact your GE Healthcare representative if you have any questions.
    [Show full text]
  • ACR Manual on Contrast Media
    ACR Manual On Contrast Media 2021 ACR Committee on Drugs and Contrast Media Preface 2 ACR Manual on Contrast Media 2021 ACR Committee on Drugs and Contrast Media © Copyright 2021 American College of Radiology ISBN: 978-1-55903-012-0 TABLE OF CONTENTS Topic Page 1. Preface 1 2. Version History 2 3. Introduction 4 4. Patient Selection and Preparation Strategies Before Contrast 5 Medium Administration 5. Fasting Prior to Intravascular Contrast Media Administration 14 6. Safe Injection of Contrast Media 15 7. Extravasation of Contrast Media 18 8. Allergic-Like And Physiologic Reactions to Intravascular 22 Iodinated Contrast Media 9. Contrast Media Warming 29 10. Contrast-Associated Acute Kidney Injury and Contrast 33 Induced Acute Kidney Injury in Adults 11. Metformin 45 12. Contrast Media in Children 48 13. Gastrointestinal (GI) Contrast Media in Adults: Indications and 57 Guidelines 14. ACR–ASNR Position Statement On the Use of Gadolinium 78 Contrast Agents 15. Adverse Reactions To Gadolinium-Based Contrast Media 79 16. Nephrogenic Systemic Fibrosis (NSF) 83 17. Ultrasound Contrast Media 92 18. Treatment of Contrast Reactions 95 19. Administration of Contrast Media to Pregnant or Potentially 97 Pregnant Patients 20. Administration of Contrast Media to Women Who are Breast- 101 Feeding Table 1 – Categories Of Acute Reactions 103 Table 2 – Treatment Of Acute Reactions To Contrast Media In 105 Children Table 3 – Management Of Acute Reactions To Contrast Media In 114 Adults Table 4 – Equipment For Contrast Reaction Kits In Radiology 122 Appendix A – Contrast Media Specifications 124 PREFACE This edition of the ACR Manual on Contrast Media replaces all earlier editions.
    [Show full text]
  • Closed Rhinoplasty: Effects and Changes on Voice - a Preliminary Report
    Topic: EuRePS Meeting 2015: best five papers Closed rhinoplasty: effects and changes on voice - a preliminary report Giuseppe Guarro, Romano Maffia, Barbara Rasile, Carmine Alfano Department of Plastic and Reconstructive Surgery, University of Perugia, 06156 Perugia, Italy. Address for correspondence: Dr. Giuseppe Guarro, Department of Plastic and Reconstructive Surgery, University of Perugia, S. Andrea delle Fratte, 06156 Perugia, Italy. E-mail: [email protected] ABSTRACT Aim: Effects of rhinoplasty were already studied from many points of view: otherwise poor is scientific production focused on changes of voice after rhinoplasty. This preliminary study analyzed objectively and subjectively these potential effects on 19 patients who underwent exclusively closed rhinoplasty. Methods: This preliminary evaluation was conducted from September 2012 to May 2013 and 19 patients have undergone primary rhinoplasty with exclusively closed approach (7 males, 12 females). All patients were evaluated before and 6 months after surgery. Each of them answered to a questionnaire (Voice Handicap Index Score) and the voice was recorded for spectrographic analysis: this system allowed to perform the measurement of the intensity and frequency of vowels (“A” and “E”) and nasal consonants (“N” and “M”) before and after surgery. Data were analysed with the Mann-Whitney test. Results: Sixteen patients showed statistically significant differences after surgery. It was detected in 69% of cases an increased frequency of emission of the consonant sounds (P = 0.046), while in 74% of cases the same phenomenon was noticed for vowel sounds (P = 0.048). Conclusion: Many patients who undergo rhinoplasty think that the intervention only leads to anatomical changes and improvement of respiratory function.
    [Show full text]
  • Hyperbaric Medicine Center During the Actual Questions About the Treatment Process Are Treatment Process, for All Patients’ Confidentiality, No Always Welcomed
    Patient Label / Name HBO - HYPERBARIC OXYGEN PATIENT EDUCATION - Page | 1 FAQs HBO is a medical treatment which enhances the body’s natural healing process by inhalation of 100% oxygen in a total body chamber, where atmospheric pressure is WHAT IS HBO? increased and controlled. It is used for a wide variety of treatments usually as an adjunctive part of an overall HBO or HBOT stands for: Hyperbaric Oxygen Therapy medical care plan that can be done on an inpatient or WHAT DOES IT DO? outpatient basis. HBO or HBOT, simply, HBOT is a means of providing WAIT! CAN YOU TELL ME MORE ABOUT THE additional oxygen to your body tissues. “ENTIRELY CLOSED PRESSURE CHAMBER”? HOW DOES IT WORK? Your entire body will go in a closely monitored, TRANSPARENT, 100% ACRYLIC topped, sealed chamber. By exposing the Most patients have plenty of room to get comfortable entire body to and can enjoy their 1.5-2 hour treatments while watching oxygen under TV (installed on each chamber with internal speakers) or increased napping. atmospheric A highly qualified Hyperbaric Tech will be in the room pressure. with you at all times during your treatment, and you will be closely monitored before, during and after all HBO The patient is entirely enclosed in a pressure chamber Treatments. breathing 100% oxygen (O2) at greater than one atmosphere HBO Chambers have microphones that allow your HBO (atm) pressure. Tech to hear you without need to push any buttons. SO, HOW DOES THAT HELP? Simply call out and you will be heard. If you should need to cut your treatment short or want to get out at any HBO therapy serves 4 PRIMARY FUNCTIONS: time, your HBO Tech is always right there to safely decompress the chamber and help you out and call for 1.
    [Show full text]
  • Laryngectomy
    The Head+Neck Center John U. Coniglio, MD, LLC 1065 Senator Keating Blvd. Suite 240 Rochester, NY 14618 Office Hours: 8-4 Monday-Friday t 585.256.3550 f 585.256.3554 www.RochesterHNC.com Laryngectomy SINUS Voice change, difficulty swallowing, unexplained weight loss, ear or ENDOCRINE HEAD AND NECK CANCER throat pain and a lump in the throat, smoking and alcohol use are all VOICE DISORDERS SALIVARY GLANDS indications for further evaluation. Smoking and alcohol can contribute TONSILS AND ADENOIDS to these symptoms. A direct laryngoscopy – an exam of larynx (voice EARS PEDIATRICS box), with biopsy – will help determine if a laryngectomy is indicated. SNORING / SLEEP APNEA Laryngectomy may involve partial or total removal of one or more or both vocal cords. Alteration of voice will occur with either total or partial laryngectomy. Postoperative rehabilitation is usually successful in helping the patient recover a voice that can be understood. The degree of alteration in voice depends on the extent of the disease. Partial or total laryngectomy has been a highly successful method to remove cancer of the larynx. The extent of the tumor invasion, and therefore the extent of surgery, determines the way you will communicate following surgery. The choice of surgery over other forms of treatment such as radiation or chemotherapy is determined by the site of the tumor. It is quite likely that there has been spread of the tumor to the neck; a neck or lymph node dissection may also be recommended. Complete neck dissection (exploration of the neck tissues) is performed in order to remove known or suspected lymph nodes containing cancer that has spread from the primary tumor site.
    [Show full text]
  • Lymphangioleiomyomatosis (LAM)
    American Thoracic Society PATIENT EDUCATION | INFORMATION SERIES Lymphangioleiomyomatosis (LAM) What is LAM? Lymphangioleiomyomatosis (lim-FAN-jee-oh-ly-oh-my-oh-ma- Pneumothroax TOE-sis), also known as LAM, is a rare lung disease that mainly Lung Cysts affects women, usually during their childbearing years. LAM occurs in 3-8 women per million in the general population. LAM is caused by mutations in the tuberous sclerosis complex (TSC) genes. These mutations lead to growth of abnormal cells that spread by the blood stream and make their way into the lungs. Once in the lungs, these cells create holes in the lung tissue (called cysts) that can weaken breathing and the ability to take up oxygen. What are the symptoms of LAM? blood protein called vascular endothelial growth factor-D Symptoms of LAM are similar to other lung diseases. Some (VEGF-D). Elevated VEGF-D levels can help confirm the times patients can be misdiagnosed with asthma, bronchitis, diagnosis of LAM without needing a lung biopsy. Blood or emphysema. These symptoms include: levels of VEGF-D should be checked before doing invasive procedures, such as lung biopsy. ■■ Shortness of breath Lung Biopsy ■■ Fatigue In most (>70%) patients, the diagnosis of LAM can be ■■ Lung collapse, also known as a pneumothorax confirmed based on clinical and/or laboratory findings and ■■ Chest pain does not require a biopsy. However, a lung biopsy may be CLIP AND COPY AND CLIP ■■ Cough needed to confirm the diagnosis of LAM in some cases. ■■ Coughing up small amounts blood There are two ways to do a lung biopsy to diagnose LAM: How is LAM diagnosed and monitored? 1.
    [Show full text]